Bioorganic and Medicinal Chemistry Letters p. 163 - 168 (1997)
Update date:2022-08-03
Topics:
Cherney, Robert J.
Swartz, Stephen G.
Patten, Arthur D.
Akamike, Emeka
Sun, Jung-Hui
Kaltenbach III, Robert F.
Seitz, Steven P.
Behrens, Carl H.
Getahun, Zelleka
Trainor, George L.
Vavala, Mike
Kirshenbaum, Mindy R.
Papp, Lisa M.
Stafford, Margaret P.
Czerniak, Philip M.
Diamond, Richard J.
McRipley, Ronald J.
Page, Roni J.
Gross, Janet L.
Unsymmetrical bis-imides 1 were synthesized and evaluated as potential antitumor agents. These novel bis-imides were assessed using three criteria: in vitro cytotoxicity (L1210), in vitro DNA binding, and in vivo studies with human tumor xenografts in mice. These studies identified DMP 315 as a potent, water soluble antitumor agent.
View MoreImprove Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
SHIJIAZHUANG AGERUO-BIOTECH CO.LTD
Contact:+86-130-2866-6699
Address:Huaian east Road 158
Tianjin Bright Future Technology Co., Ltd
Contact:0086-22-58016666
Address:NO.136 DongTeng Lake Street Tianjin Economic and Technology Development Area,Tainjin,China
Qingdao Pana-Life Biochem Co.,Ltd.
Contact:86-532-87683902
Address:No.967 Dalao Road, Licang Zone, Qingdao City,Shandong, China 266021
Ningbo Distant Chemicals Co.,Ltd
Contact:86-574-27862490,27862438
Address:5F-3,#54 DaShaNi street,Ningbo,CHINA
Doi:10.1021/ja00512a045
(1979)Doi:10.13005/ojc/310168
(2015)Doi:10.1039/P19790001729
(1979)Doi:10.1021/ja01500a026
(1960)Doi:10.1007/s11164-015-2373-y
(2016)Doi:10.1016/S0040-4039(01)80784-X
(1989)
